Literature DB >> 20847873

The Dark Side of the Moon - the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management.

Richard Greil1.   

Abstract

Entities:  

Year:  2009        PMID： 20847873      PMCID： PMC2931000          DOI： 10.1159/000225388

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  38 in total

1.  Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.

Authors:  Catherine M Bender; Susan M Sereika; Adam M Brufsky; Christopher M Ryan; Victor G Vogel; Priya Rastogi; Susan M Cohen; Frances E Casillo; Sarah L Berga
Journal:  Menopause       Date:  2007 Nov-Dec       Impact factor: 2.953

2.  Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer.

Authors:  G Batist; G Ramakrishnan; C S Rao; A Chandrasekharan; J Gutheil; T Guthrie; P Shah; A Khojasteh; M K Nair; K Hoelzer; K Tkaczuk; Y C Park; L W Lee
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

Review 3.  Timeline: Chemotherapy and the war on cancer.

Authors:  Bruce A Chabner; Thomas G Roberts
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

4.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

5.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Authors:  Edward H Romond; Edith A Perez; John Bryant; Vera J Suman; Charles E Geyer; Nancy E Davidson; Elizabeth Tan-Chiu; Silvana Martino; Soonmyung Paik; Peter A Kaufman; Sandra M Swain; Thomas M Pisansky; Louis Fehrenbacher; Leila A Kutteh; Victor G Vogel; Daniel W Visscher; Greg Yothers; Robert B Jenkins; Ann M Brown; Shaker R Dakhil; Eleftherios P Mamounas; Wilma L Lingle; Pamela M Klein; James N Ingle; Norman Wolmark
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

6.  Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer.

Authors:  G Frasci; P Comella; M Rinaldo; G Iodice; M Di Bonito; M D'Aiuto; A Petrillo; S Lastoria; C Siani; G Comella; G D'Aiuto
Journal:  Ann Oncol       Date:  2009-02-13       Impact factor: 32.976

Review 7.  Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review.

Authors:  Jeffrey M Peppercorn; Jane C Weeks; E Francis Cook; Steven Joffe
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

Review 8.  Part II: Hodgkin's lymphoma--diagnosis and treatment.

Authors:  Volker Diehl; Roman K Thomas; Daniel Re
Journal:  Lancet Oncol       Date:  2004-01       Impact factor: 41.316

9.  Breast cancer survivors in the United States: geographic variability and time trends, 2005-2015.

Authors:  Roberta De Angelis; Andrea Tavilla; Arduino Verdecchia; Steve Scoppa; Mark Hachey; Eric J Feuer; Angela B Mariotto
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

10.  Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

Authors:  Nikolaos Xenidis; Michail Ignatiadis; Stella Apostolaki; Maria Perraki; Kostas Kalbakis; Sofia Agelaki; Efstathios N Stathopoulos; Grigorios Chlouverakis; Evi Lianidou; Stylianos Kakolyris; Vassilis Georgoulias; Dimitris Mavroudis
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544
View more
  1 in total

1.  Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine.

Authors:  Andreia de Albuquerque; Sepp Kaul; Georg Breier; Petra Krabisch; Nikos Fersis
Journal:  Breast Care (Basel)       Date:  2012-02-21       Impact factor: 2.860
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.